Transplant Rejection Medications

25 · 50mg

designed to address chronic inflammation to target immune system activity.

500mg

Designed to support immune system regulation, indicated to prevent organ rejection in transplant recipients.

25 · 50 · 100mg

Formulated to mitigate immune responses, utilized to support organ transplant maintenance.

25 · 50mg

Developed to target immune system activity, utilized to mitigate inflammation in autoimmune processes and to support transplant rejection prevention.

25 · 100mg

This medication is intended to support the immune system and is indicated to alleviate risks associated with organ transplant rejection.

0.5 · 1 · 5mg

Designed to mitigate transplant rejection to support long-term organ health.

1mg

Developed to target the immune response and indicated to support transplant success, this agent is utilized to alleviate the risk of organ rejection.